OBJECTIVES: To describe long-term mortality rate and to assess associations between mortality rate and antibiotic treatment of lower respiratory infection in patients with advanced dementia; antibiotic treatment allocation was independent of mortality risk-leaving less room for biased associations than in previous multicenter observational studies. DESIGN: Prospective study (2004-2009). Multilevel Cox proportional hazard analyses with adjustment for mortality risk were used to assess associations between antibiotics and mortality using time-dependent covariates. SETTING: A US Department of Veterans Affairs nursing home. PARTICIPANTS: Ninety-four residents with advanced dementia who developed 109 episodes. MEASUREMENTS: Survival, treatment, mortality risk, illness severity, fluid intake, and several other patient characteristics. RESULTS: Ten-day mortality was 48%, and 6-month mortality was 74%. Antibiotics were used in 77% of episodes. Overall, antibiotics were not associated with mortality rate (Hazard Ratio [HR] 0.70, Confidence Interval [CI] 0.38-1.30); however, antibiotics were associated with reduced 10-day mortality rate (HR 0.51, CI, 0.30-0.87; rate after 10 days: 1.5, CI 0.42-5.2). Benefit from antibiotics was less likely with inadequate fluid intake, and when experiencing the first episode. CONCLUSION: In our sample of male nursing home residents with advanced dementia and lower respiratory infection, mortality was substantial despite antibiotic treatment. Antibiotics prolonged life but in many cases only for several days. Treatment decisions should take into account that antibiotics may delay death but may also prolong the dying process, indicating a need for accurate prediction of mortality and study of characteristics that may alter effectiveness of antibiotics.
OBJECTIVES: To describe long-term mortality rate and to assess associations between mortality rate and antibiotic treatment of lower respiratory infection in patients with advanced dementia; antibiotic treatment allocation was independent of mortality risk-leaving less room for biased associations than in previous multicenter observational studies. DESIGN: Prospective study (2004-2009). Multilevel Cox proportional hazard analyses with adjustment for mortality risk were used to assess associations between antibiotics and mortality using time-dependent covariates. SETTING: A US Department of Veterans Affairs nursing home. PARTICIPANTS: Ninety-four residents with advanced dementia who developed 109 episodes. MEASUREMENTS: Survival, treatment, mortality risk, illness severity, fluid intake, and several other patient characteristics. RESULTS: Ten-day mortality was 48%, and 6-month mortality was 74%. Antibiotics were used in 77% of episodes. Overall, antibiotics were not associated with mortality rate (Hazard Ratio [HR] 0.70, Confidence Interval [CI] 0.38-1.30); however, antibiotics were associated with reduced 10-day mortality rate (HR 0.51, CI, 0.30-0.87; rate after 10 days: 1.5, CI 0.42-5.2). Benefit from antibiotics was less likely with inadequate fluid intake, and when experiencing the first episode. CONCLUSION: In our sample of male nursing home residents with advanced dementia and lower respiratory infection, mortality was substantial despite antibiotic treatment. Antibiotics prolonged life but in many cases only for several days. Treatment decisions should take into account that antibiotics may delay death but may also prolong the dying process, indicating a need for accurate prediction of mortality and study of characteristics that may alter effectiveness of antibiotics.
Authors: Jenny T van der Steen; Robin L Kruse; Marcel E Ooms; Miel W Ribbe; Gerrit van der Wal; Lawrence L Heintz; David R Mehr Journal: J Am Geriatr Soc Date: 2004-05 Impact factor: 5.562
Authors: Margaret R Helton; Jenny T van der Steen; Timothy P Daaleman; George R Gamble; Miel W Ribbe Journal: Ann Fam Med Date: 2006 May-Jun Impact factor: 5.166
Authors: Jenny T van der Steen; David R Mehr; Robin L Kruse; Ashley K Sherman; Richard W Madsen; Ralph B D'Agostino; Marcel E Ooms; Gerrit van der Wal; Miel W Ribbe Journal: J Clin Epidemiol Date: 2006-05-23 Impact factor: 6.437
Authors: Jenny T van der Steen; David R Mehr; Robin L Kruse; Miel W Ribbe; Gerrit van der Wal Journal: J Am Med Dir Assoc Date: 2007-06-14 Impact factor: 4.669
Authors: Tessa van der Maaden; Simone A Hendriks; Henrica C W de Vet; Menno T Zomerhuis; Martin Smalbrugge; Elise P Jansma; Raymond T C M Koopmans; Cees M P M Hertogh; Jenny T van der Steen Journal: Drugs Aging Date: 2015-01 Impact factor: 3.923
Authors: Andrea J Loizeau; Nathan Theill; Simon M Cohen; Stefanie Eicher; Susan L Mitchell; Silvio Meier; Michelle McDowell; Mike Martin; Florian Riese Journal: Age Ageing Date: 2019-01-01 Impact factor: 10.668
Authors: Miriam L Haaksma; Maria Eriksdotter; Debora Rizzuto; Jeannie-Marie S Leoutsakos; Marcel G M Olde Rikkert; René J F Melis; Sara Garcia-Ptacek Journal: Neurology Date: 2019-12-16 Impact factor: 9.910
Authors: Simone P Rauh; Martijn W Heymans; David R Mehr; Robin L Kruse; Patricia Lane; Neil W Kowall; Ladislav Volicer; Jenny T van der Steen Journal: BMJ Open Date: 2016-08-30 Impact factor: 2.692
Authors: Ruth Piers; Gwenda Albers; Joni Gilissen; Jan De Lepeleire; Jan Steyaert; Wouter Van Mechelen; Els Steeman; Let Dillen; Paul Vanden Berghe; Lieve Van den Block Journal: BMC Palliat Care Date: 2018-06-21 Impact factor: 3.234